tm
Seeing Is Believing
tm
Seeing Is Believing
BBIO is currently covered by 9 analysts with an average potential upside of $14.72 (47.36%) from yesterday's end of day stock price of $28.71. BridgeBio Pharma activity chart has currently 44 price targets and 70 ratings on display.
Analysts average stock forecasts to be materialized ratio is 69.15% with an average time for these price targets to be met of 170.42 days.
Highest price target for BBIO is $33, Lowest price target is $7, average price target is $20.
Most recent stock forecast was given by SALIM SYED from MIZUHO on 28-Aug-2023. First documented stock forecast 22-Jul-2019.
Currently, out of the existing stock ratings of BBIO - 35 which are a Buy (100%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
60
$31.29 (108.99%)
60
3 months 6 days ago
6/11 (54.55%)
$19.23 (67.94%)
240
Buy
38
$9.29 (32.36%)
42
3 months 17 days ago
6/9 (66.67%)
$9.56 (61.04%)
154
Buy
27
$-1.71 (-5.96%)
26
7 months 21 days ago
8/11 (72.73%)
$11.37 (48.47%)
266
Buy
30
$1.29 (4.49%)
30
8 months 4 days ago
2/2 (100%)
$13.96 (87.94%)
334
Buy
18
$-10.71 (-37.30%)
18
8 months 5 days ago
2/2 (100%)
$-0.06 (-0.23%)
46
What is BBIO (BridgeBio Pharma) average time for price targets to be met?
Which analyst has the current highest performing score on BBIO (BridgeBio Pharma) with a proven track record?
Which analyst has the most public recommendations on BBIO (BridgeBio Pharma)?
Which analyst is the currently most bullish on BBIO (BridgeBio Pharma)?
Which analyst is the currently most reserved on BBIO (BridgeBio Pharma)?
